Evidence map›Paper›PMID 41211234›Full record

ArticleThe East African health research journal2025

Reported Adverse Events (Side Effects) Following COVID-19 Vaccination Among University Students and Staff: A Case of Islamic University in Uganda.

Rashid Naziru, Madinah Nabukeera Ssebyala, Francis Tamale, Zakariyah Mukasa, John Turyagumanawe, Alex Daama, Areemu Abdul Mujeeb Babatunde, Swaibu Zziwa, Kharim Mwebaza Muluya

Abstract read
In one paragraph

Article in The East African health research journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rashid NaziruDepartment of Public Health; Faculty of Health sciences; Islamic University in Uganda.
Madinah Nabukeera SsebyalaFaculty of Management Studies Islamic University in Uganda.
Francis TamaleMinistry of Health Uganda.
Zakariyah MukasaMakerere University school of public health.
John TuryagumanaweMakerere University school of public health.
Alex DaamaRakai health sciences program.
Areemu Abdul Mujeeb BabatundeDepartment of Public Health; Faculty of Health sciences; Islamic University in Uganda.
Swaibu ZziwaDepartment of Public Health; Faculty of Health sciences; Islamic University in Uganda.
Kharim Mwebaza MuluyaDepartment of Public Health; Faculty of Health sciences; Islamic University in Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Since its outbreak, COVID-19 has brought several disastrous effects on the healthcare and economic systems of different countries globally. There is still no approved curative medicine for COVID-19; thus, the disease can only be controlled through preventive measures, especially vaccination through herd immunity. However, this is still far from being realized, as vaccination is still being affected by hesitancy and resistance from people, mainly due to the fears of side effects and other adverse events following vaccination. Therefore, understanding the incidence and associated factors, nature, and management of these adverse events is paramount for ensuring public confidence in vaccination programmes. The current study therefore aimed at documenting reported adverse events following COVID-19 vaccination among students and staff at the Islamic university in Uganda. Methodology: This was a cross-sectional study design that was prospective in nature that recruited staff and students from Islamic University in Uganda that received COVID-19 vaccination between February and June 2022. Data was collected using Google Forms; participants were reached through the institutional ERP, emails, text messages and WhatsApp (social media). Data analysis was done using SPSS version 20. Results: The study recruited 225 participants; 64.0% were female, and the median age range was between 26 and 30 years. Most of the respondents, 76.4%, reported receiving at least one side effect. More than 73% did not report any comorbidity (chronic conditions). 70.5% had received two doses of COVID-19 vaccines, and AstraZeneca was the most received brand at 51.8%. Most participants reported minor side effects, including pain at the injection site (44.4%). fever, chills, headache, and dizziness at 18.1%, and muscle pains and backpains at 14.6%. Only 1.2% reported vaccine sexual reproductive health. Conclusions and Recommendation: The study confirms that COVID-19 vaccines are safe, as most of the reported side effects were minor with no life-threatening events. More sensitization of the community about the safety of vaccines is encouraged. Ongoing pharmacovigilance surveys for COVID-19 vaccines are recommended to detect possible long-term side effects.

Identifiers

PMID41211234
PMCPMC12591008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.